Home

Tuesday, 29 April 2025

Apiculture Market Size, Share, Growth Analysis Report, 2030

 The global apiculture market size was estimated at USD 8.95 billion in 2023 and is projected to grow at a CAGR of 4.0% from 2024 to 2030, owing to the versatility of bee products extends beyond food and beverages. They are integral to various sectors, including pharmaceuticals, cosmetics, and agriculture. For instance, honey and royal jelly are commonly used in dietary supplements, while beeswax is a popular ingredient in skincare products. This broad applicability enhances the market’s resilience and growth potential as different industries increasingly invest in bee-related products to meet consumer demands.

Type Insights

Honey product dominated the market with a revenue share of 50.2% in 2023. Honey is the most prominent product in the apiculture market, known for its natural sweetness and numerous health benefits. Initially valued primarily for its medicinal properties, honey has evolved into a staple ingredient in the food and beverage industry. Its popularity is driven by a rising consumer preference for natural sweeteners over artificial alternatives, leading to increased exploration and innovation within the honey sector.

End-use Insights

Food & beverages end use dominated the market with a revenue share of 43.3% in 2023.The food and beverage sector remains the largest end-use application for bee products, particularly honey. As consumers become more health-conscious, there is a notable shift from artificial sweeteners to natural alternatives, with honey being a preferred choice due to its rich flavor and health benefits.

Regional Insights

Asia Pacific Apiculture Market Trends

Asia Pacific dominated the market segment with a revenue share of 35.6% in 2023. The demand for honey is surging in the Asia Pacific region, fueled by a shift towards natural sweeteners in food and beverages.
Key Apiculture Companies:

The following are the leading companies in the apiculture market. These companies collectively hold the largest market share and dictate industry trends.

  • Capilano Honey Ltd.
  • Organic Bee Farms
  • Dabur Ltd.
  • NOW Foods
  • Koster Keunen LLC
  • Barkman Honey
  • Heavenly Organics
  • Strahl & Pitsch Inc.
  • Miller’s Honey
  • Durham’s Bee Farm
  • Type Outlook (Volume, Kilotons; Revenue, USD Million; 2018–2030)
  • Honey
  • Beeswax
  • Propolis
  • Others
  • End Use Outlook (Volume, Kilotons; Revenue, USD Million; 2018–2030)
  • Medical
  • Food & Beverages
  • Cosmetics
  • Others

Metallized Films Market Size To Reach $4.2 Billion By 2030

 

Metallized Films Market Growth & Trends

The global metallized films market size is anticipated to reach USD 4.2 billion by 2030 and is projected to grow at a CAGR of 7.5% during the forecast period, according to a new report by Grand View Research, Inc. The metallized films industry is experiencing significant growth driven primarily by the expanding packaging industry, particularly in food and beverages. These films provide excellent barrier properties against moisture, oxygen, and light, thereby extending product shelf life. For example, potato chip bags and coffee packaging commonly use metallized films to maintain product freshness and prevent degradation from environmental factors.

The sustainability trend is another crucial driver, as metallized films offer advantages over traditional aluminum foil. They require less material and energy to produce, resulting in a lower carbon footprint. In addition, some metallized films can be made from recyclable materials, addressing growing environmental concerns.

The electronics and solar energy sectors are emerging as significant growth drivers for metallized films. These materials are increasingly used in capacitors, flexible electronics, and solar panels due to their excellent electrical and thermal properties. For example, metallized polyester films are crucial components in photovoltaic cells, where they serve as backing sheets that protect solar panels from environmental damage while maintaining efficiency.

The rise of e-commerce and changing consumer preferences have led to increased demand for flexible packaging solutions, where metallized films play a vital role. These films are particularly popular in the personal care and cosmetics industry, where they provide both functional benefits and aesthetic appeal. Leading brands such as L’Oréal and Unilever frequently use metallized film packaging for premium products, leveraging its metallic finish to enhance shelf appeal while ensuring product protection. The Asia-Pacific region, particularly China and India, is witnessing the fastest growth in this market due to rapid industrialization and increasing disposable income.

Request a free sample copy or view report summary:
Metallized Films Market Report

Metallized Films Market Report Highlights

  • The aluminum metal segment held the largest share of over 66.0% of the market in 2024 and is projected to grow at the fastest CAGR of 7.8% during the forecast period.
  • Based on material, the Polypropylene (PP) material segment dominated the market in 2024 by accounting for the largest revenue share of over 47.0%.
  • Polyethylene Terephthalate (PET) material segment is expected to grow at the fastest CAGR of 7.9% during the forecast period.
  • The packaging segment held the largest market share, exceeding 41.0% in 2024, and is projected to grow at the fastest CAGR of 7.8% from 2025 to 2030.
  • In December 2023, Cosmo Films launched metalized electrical grade BOPP films specifically designed for capacitor applications. The metalized films can be utilized in the manufacturing of AC and DC capacitors, which have diverse applications ranging from consumer electronics to industrial power systems and electric vehicles. The thickness of the films will range from 2.5 microns to 12 microns, catering to different performance requirements.

Metallized Films Market Segmentation

Grand View Research has segmented the global metallized films market based on metal, material, and end use:

Metallized Films Metal Outlook (Revenue, USD Million, 2018–2030)

  • Aluminum
  • Others

Metallized Films Material Outlook (Revenue, USD Million, 2018–2030)

  • Polypropylene (PP)
  • Polyethylene Terephthalate (PET)
  • Others

Metallized Films End Use Outlook (Revenue, USD Million, 2018–2030)

  • Packaging
  • Decorative
  • Others

Metallized Films Regional Outlook (Revenue, USD Million, 2018–2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Central & South America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Metallized Films Market

  • Toray Industries
  • Cosmo Films
  • Polibak
  • DUNMORE
  • Jindal Poly Films Limited
  • Sumilon Group
  • Flex Films
  • SUKI CREATIONS PVT. LTD.
  • Nahar PolyFilms Ltd.
  • Zhejiang Changyu New Materials Co., Ltd.
  • Paragon Poly Films Pvt Ltd.
  • Qingdao Cloud film Packaging materials Co., Ltd.
  • Emperial Films LLP
  • FILIRIKO

Drug Screening Market Size To Reach $11.99 Billion By 2030

 

Drug Screening Market Growth & Trends

The global drug screening market size is anticipated to reach USD 11.99 billion by 2030 and is growing at a CAGR of 4.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by increasing workplace safety concerns, regulatory compliance, and requirement for accurate detection of substance abuse, aided by technological advancements in testing methods.

The increase in number of adults in contact with drug and alcohol services in England has increased from 275,896 in 2020–2021­ to 289,215 in 2021–2022, representing a 4.8% rise, which signifies a growing prevalence of substance abuse in the country. The rising prevalence of substance abuse further propels the need for effective prevention and treatment strategies, including the expansion of access to evidence-based treatment options and public health campaigns to raise awareness about the risks of drug and alcohol misuse.

Similarly, the incidence of illegal substance use among Americans aged 12 and older in 2020 was around 37.31 million, and shows a 3.8% year-over-year increase over the years; this rising prevalence serves as a significant driver for the market. This increase highlights the urgent need for comprehensive drug screening programs in workplaces, schools, and healthcare settings to ensure safety, compliance with regulations, and provision of appropriate care and support for individuals struggling with substance abuse.

Furthermore, initiatives by market players such as new product launches, mergers, acquisitions, and others contribute to market growth. For instance, in February 2024, Mobile Health, the leading drug testing provider in NYC, introduced rapid drug testing for employers, ensuring results in an hour or less. With a focus on urine-based testing for accuracy and versatility, this innovation advances the hiring process, revolutionizing talent acquisition in NYC. In addition, in December 2023, the FDA’s approval of the AvertD test, which assesses an individual’s risk of developing opioid use disorder through genetic markers, marks a significant innovation in the fight against the opioid crisis. This test, developed by AutoGenomics, Inc., is designed to be used before a patient is first exposed to oral opioid pain medications, particularly in patients scheduled for surgical procedures. The test is intended to help patients and healthcare providers make informed decisions about opioid use, potentially reducing the risk of addiction and misuse.

The approval of AvertD is part of FDA’s broader efforts to address opioid crisis, which includes the introduction of FDA Overdose Prevention Framework in August 2022 and the approval of nonprescription naloxone nasal spray products in March and July 2023. The FDA’s commitment to addressing these crisis is evident in its continued support for the development of medical devices that can help assess and mitigate the risk of opioid use disorder.

Request a free sample copy or view report summary:
Drug Screening Market Report

Drug Screening Market Report Highlights

  • Consumables dominated the product type segment with the fastest revenue market share in 2023 and is anticipated to grow at fastest growth rate over the forecast period owing to extensive R&D initiatives undertaken by major players to develop kits
  • Based on type segment, urine sample dominated the market with the largest revenue share in 2023 attributed to the ease of collection. Urine drug testing is generally more cost-effective compared to other testing methods, such as hair testing
  • Drug treatment centers end-use segment dominated the market in 2023, attributed to the increasing focus on substance abuse treatment and rehabilitation, leading to a higher demand for drug testing services in these centers
  • North America dominated the global market owing to factors such as advanced healthcare infrastructure, the region’s high consumption of illegal substances, and the necessity for workplace drug tests

Drug Screening Market Segmentation

Grand View Research has segmented the global drug screening market based on product type, sample type, end-use, and region:

Drug Screening Product Type Category Outlook (Revenue, USD Million, 2018–2030­)

  • Instruments
  • Immunoassays Analyzers
  • Chromatography Instruments
  • Breath Analyzer
  • Fuel Cell Breath Analyzer
  • Semi-Conductor Breath Analyzer
  • Others Breath Analyzer
  • Rapid Testing Devices
  • Urine Testing Devices
  • Drug Testing Cups
  • Dip Cards
  • Drug Testing Cassettes
  • Oral Fluid Testing Devices
  • Consumables
  • Assay Kits
  • Sample Collection Devices
  • Calibrators & Controls
  • Other Consumables
  • Services and Others

Drug Screening Sample Type Outlook (Revenue, USD Million, 2018–2030)

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples

Drug Screening End-use Outlook (Revenue, USD Million, 2018–2030)

  • Hospitals
  • Criminal Justice & Law Enforcement Agencies
  • Workplaces
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools & Colleges
  • Others

Drug Screening Region Outlook (Revenue, USD Million, 2018–2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Drug Screening Market

  • Abbott
  • Quest Diagnostics Incorporated
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Siemens Healthcare AG
  • Laboratory Corporation of America Holdings
  • Alfa Scientific Designs, Inc.
  • OraSure Technologies, Inc.
  • Omega Laboratories, Inc.
  • Drägerwerk AG & Co. KGaA
  • Bio-Rad Laboratories, Inc.